Product Information

NYLIA 1-35 28 TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1936 per EA under NDC 65862089888. Its NADAC has been published 243 times since Mar 23, 2022.

FDA first approved this application on Oct 21, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NYLIA 1-35 28 TABLET

Norethindrone and Ethinyl Estradiol
$0.1936per EA

NDC

65862089888

Classification

Generic

Dosage Form

KIT

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207056

FDA Approved

10/21/2016

TE Code

AB

On Market Since

10/21/2016

Price Statistics

The NADAC for NYLIA 1-35 28 TABLET has been published 243 times since Mar 23, 2022, and over the history we have for it it has declined 43.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1936 per EA
All-time high$0.3717 (Jul 13, 2022)
All-time low$0.1935 (May 22, 2024)
52-week high$0.2225
52-week low$0.1936
Median price$0.2458
Average price$0.2622
Largest weekly change+39.2% (Jun 19, 2024)
Weeks tracked243
Tracking sinceMar 23, 2022

Price History

1W

0.0%

1M

-4.5%

3M

-7.5%

6M

-2.3%

1Y

-11.6%

3Y

-29.3%

5Y

N/A

All

-43.5%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NYLIA 1-35 28 TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NYLIA 1-35 28 TABLET, manufactured by Aurobindo Pharma Limited, is $0.1936 per EA (NDC 65862089888), effective Nov 11, 2026.

How has the price of NYLIA 1-35 28 TABLET changed over time?

Over the history we have for it, the NADAC for NYLIA 1-35 28 TABLET has declined 43.5%. It has been tracked across 243 weekly CMS publications since Mar 23, 2022.

What are the highest and lowest recorded NADAC prices for NYLIA 1-35 28 TABLET?

Since Mar 23, 2022, the NADAC for NYLIA 1-35 28 TABLET has ranged from a low of $0.1935 (May 22, 2024) to a high of $0.3717 (Jul 13, 2022), with a median of $0.2458 per EA.

Are there cheaper alternatives to NYLIA 1-35 28 TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NYLIA 1-35 28 TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures NYLIA 1-35 28 TABLET?

NYLIA 1-35 28 TABLET (NDC 65862089888) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.